Neo Ivy Capital Management - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$66
-35.3%
2,424
-47.3%
0.03%
-46.3%
Q2 2023$102
-77.5%
4,602
-79.4%
0.05%
-82.4%
Q4 2022$453
-77.4%
22,314
+37720.3%
0.31%
+6040.0%
Q3 2022$2,000
-98.2%
59
-98.8%
0.01%
-95.0%
Q1 2022$112,000
+229.4%
4,980
+225.7%
0.10%
+197.1%
Q2 2021$34,000
-89.3%
1,529
-88.6%
0.03%
-90.3%
Q1 2021$319,000
+3887.5%
13,419
+2531.2%
0.35%
+4275.0%
Q3 2020$8,0005100.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders